Clinical Trials and Translational Research Advisory Committee
Presentations from the 9th Meeting Held November 4, 2009
(Presentation File Format - PDF --> Get Adobe Reader)
November 4
| Director's Update | Dr. Niederhuber |
| Legislative Update | Ms. Erickson |
| Operational Efficiency Working Group (OEWG) Update | Dr. Doroshow Dr. Hortobagyi |
| Update on Cooperative Group Clinical Trial Complexity Funding | Dr. Mooney |
| Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP): 2010 Program Changes | Dr. Petryshyn |
| A Randomized Phase III Double-Blind Trial Evaluating Selective COX-2 Inhibition in COX-2 Expressing Advanced Non-Small Cell Lung Cancer | Dr. Dansky Ullmann |
| Central Institutional Review Board (CIRB): Revised Procedures, Accreditation Update and Cost-Benefit Analysis | Dr. Goldberg Dr. Mooney Dr. Wagner |
| Issues Related to the Revision of the Intellectual Property Option in DCTD Sponsored Clinical Trials | Dr. Ansher Dr. Abrams Dr. Cristofaro |
| NCI's Experimental Therapeutics Program (NExT) | Dr. Doroshow |
| Update on the Translational Research Acceleration Initiative | Dr. Matrisian |
| Immune Response Modifiers (IRM) Prioritization Working Group Report | Dr. Cheever |